D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$880M |
| 3 |
Boeing
BA
|
+$850M |
| 4 |
Eli Lilly
LLY
|
+$689M |
| 5 |
Tesla
TSLA
|
+$665M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$964M |
| 2 |
Apple
AAPL
|
+$606M |
| 3 |
Workday
WDAY
|
+$520M |
| 4 |
Palantir
PLTR
|
+$514M |
| 5 |
Spotify
SPOT
|
+$431M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.54% |
| 2 | Consumer Discretionary | 8.87% |
| 3 | Healthcare | 8.21% |
| 4 | Financials | 5.68% |
| 5 | Industrials | 4.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
PUT
Tandem Diabetes Care
TNDM
$1.22B
| $612K | ﹤0.01% |
+17,000
| New | +$575K |
|
3352
Cadence Design Systems
CDNS
$95.9B
| $610K | ﹤0.01% |
2,031
-5,471
| -73% | -$1.59M |
|
3353
Southern Missouri Bancorp
SMBC
$868M
| $610K | ﹤0.01% |
10,635
-1,166
| -10% | -$71.6K |
|
3354
Euroseas
ESEA
$534M
| $609K | ﹤0.01% |
20,684
-26,581
| -56% | -$872K |
|
3355
PUT
Teekay Tankers
TNK
$2.66B
| $609K | ﹤0.01% |
+15,300
| New | +$708K |
|
|
RWT
3356
Redwood Trust
RWT
$573M
| $607K | ﹤0.01% |
+93,012
| New | +$669K |
|
|
SCS
3357
DELISTED
Steelcase
SCS
| $607K | ﹤0.01% |
51,352
-59,862
| -54% | -$770K |
|
3358
Heritage Insurance Holdings
HRTG
$899M
| $607K | ﹤0.01% |
50,145
-75,172
| -60% | -$867K |
|
3359
PUT
Dine Brands
DIN
$452M
| $605K | ﹤0.01% |
20,100
-36,600
| -65% | -$1.18M |
|
3360
CALL
Boston Properties
BXP
$11B
| $602K | ﹤0.01% |
+8,100
| New | +$657K |
|
3361
Energy Fuels
UUUU
$2.81B
| $601K | ﹤0.01% |
117,051
+64,985
| +125% | +$402K |
|
3362
CALL
Colgate-Palmolive
CL
$75.1B
| $600K | ﹤0.01% |
6,600
| – | – |
|
|
CYBR
3363
PUT
DELISTED
CyberArk
CYBR
| $600K | ﹤0.01% |
1,800
-161,200
| -99% | -$49M |
|
3364
ReNew
RNW
$2.23B
| $599K | ﹤0.01% |
87,771
+33,475
| +62% | +$204K |
|
3365
PUT
MP Materials
MP
$7.28B
| $599K | ﹤0.01% |
38,400
-2,100
| -5% | -$38.9K |
|
3366
HUTCHMED
HCM
$1.93B
| $599K | ﹤0.01% |
41,543
-51,734
| -55% | -$924K |
|
3367
CALL
Transmedics
TMDX
$2.56B
| $599K | ﹤0.01% |
9,600
| – | – |
|
3368
Utah Medical Products
UTMD
$226M
| $597K | ﹤0.01% |
9,708
-405
| -4% | -$26.2K |
|
3369
O'Reilly Automotive
ORLY
$76.4B
| $596K | ﹤0.01% |
7,545
-34,500
| -82% | -$2.78M |
|
3370
Cullinan Oncology
CGEM
$1.04B
| $596K | ﹤0.01% |
48,932
-10,308
| -17% | -$148K |
|
3371
Orion Group Holdings
ORN
$479M
| $596K | ﹤0.01% |
81,260
+17,934
| +28% | +$130K |
|
|
EVGR
3372
DELISTED
Evergreen Corporation Class A Ordinary Share
EVGR
| $594K | ﹤0.01% |
50,000
| – | – |
|
3373
CALL
Saia
SAIA
$11B
| $592K | ﹤0.01% |
1,300
-7,900
| -86% | -$3.91M |
|
|
SCHV
3374
Schwab US Large-Cap Value ETF
SCHV
$15.8B
| $592K | ﹤0.01% |
+22,722
| New | +$613K |
|
3375
PUT
Trane Technologies
TT
$103B
| $591K | ﹤0.01% |
+1,600
| New | +$635K |
|
Similar funds
D.E. Shaw & Co's Q4 2024 Portfolio in Review
As of Q4 2024, D.E. Shaw & Co held 5,079 positions worth $136B, up 17% from $116B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co deployed $10.6B of net new capital in Q4 2024, opening 591 new positions and adding to 1,620 existing holdings. Its largest new stake was Lam Research: 3,525,438 shares worth $255M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was NVIDIA, an estimated $964M trimmed.
- D.E. Shaw & Co's largest Q4 2024 buy was Lam Research: 3,525,438 shares worth $255M.
- D.E. Shaw & Co added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $3.7B increase.
- D.E. Shaw & Co's biggest Q4 2024 reduction was NVIDIA, cutting an estimated $964M.
- D.E. Shaw & Co fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $81.4M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $136B portfolio in Q4 2024.
- D.E. Shaw & Co opened 591 new positions and closed 731 in Q4 2024.
- D.E. Shaw & Co's portfolio value rose 17% quarter-over-quarter to $136B.
Based on D.E. Shaw & Co's 13F filing for Q4 2024, filed 14 Feb 2025.